Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

20.580
+0.1200.59%
Volume:297.00K
Turnover:6.07M
Market Cap:54.72B
PE:19.84
High:21.200
Open:21.200
Low:20.120
Close:20.460
52wk High:29.000
52wk Low:12.535
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:0.27
T/O Rate:0.05%
Dividend:0.35
Dividend Rate:1.70%
EPS(LYR):1.037
ROE:6.75%
ROA:1.32%
PB:1.00
PE(LYR):19.84
PS:1.22

Loading ...

Fosun Pharma Unit Gets China Acceptance for Anesthesia Drug Application

MT Newswires Live
·
Feb 13

Fosun Pharma (600196) Announces Acceptance of Subsidiary’s New Drug Registration Application

Bulletin Express
·
Feb 13

Fosun Pharma (600196) Announces Acceptance of Subsidiary’s Cisplatin Injection Registration Application

Bulletin Express
·
Feb 13

FOSUN PHARMA's Cisplatin Injection Marketing Application Accepted for Review

Stock News
·
Feb 13

Fosun Pharma Gets Regulatory Approval for Myeloma Drug Trial

MT Newswires Live
·
Feb 13

Fosun Pharma Unit Gets China Acceptance for Application of Local Anaesthetic

MT Newswires Live
·
Feb 10

Fosun Pharma (600196, 02196) Announces Subsidiary’s Tetracaine Hydrochloride Gel Registration Accepted

Bulletin Express
·
Feb 10

Fosun Pharma (600196, 02196) Announces Acceptance of Subsidiary’s Cyclophosphamide Injection Registration

Bulletin Express
·
Feb 05

FOSUN PHARMA's Cyclophosphamide Injection Application Accepted for Review

Stock News
·
Feb 05

Fosun Pharma (600196.SH / 02196.HK) Receives Acceptance for Additional Indication of Luvometinib Tablets

Bulletin Express
·
Feb 05

Fosun Pharma's Subsidiary Henlius Enters Licensing Agreement with Eisai for Cancer Treatment

Stock News
·
Feb 05

Fosun Pharma (02196) Announces Proposed Spin-off of Fosun Adgenvax

Bulletin Express
·
Feb 04

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196): Notice of 2026 First Class Meeting of H Shareholders

Bulletin Express
·
Feb 04

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Stock Code: 02196) Publishes 2026 First EGM and H Shareholders’ Class Meeting Circular

Bulletin Express
·
Feb 04

Fosun Pharma Sells 1 Billion Yuan Bonds

MT Newswires Live
·
Feb 03

Fosun Pharma (02196) Completes Issuance of First Tranche of 2026 Scientific and Technological Innovation Bonds

Bulletin Express
·
Feb 03

Fosun Pharma Plans to Spin Off Vaccine Subsidiary for Hong Kong Listing, Reports 2024 Loss of 120 Million Yuan

Deep News
·
Jan 23

BUZZ-Shanghai Fosun Pharmaceutical climbs on vaccine unit's Hong Kong listing plan

Reuters
·
Jan 23

Fosun Pharmaceutical Unit Wins China Approval for Norepinephrine Injection

MT Newswires Live
·
Jan 23

Shanghai Fosun Pharmaceutical (02196) Announces Proposed Spin-Off of Fosun Adgenvax for Main Board Listing

Bulletin Express
·
Jan 22